Savara Pharmaceuticals appoints two board members
December 9, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Joseph McCracken, Pikover, savara
Speciality pharma firm Savara Pharmaceuticals has appointed Dr Joseph McCracken and Yuri Pikover to its board of directors. McCracken has …
EMA in new Iclusig probe
December 9, 2013Sales and Marketing Ariad, EMA, iclusig, leukaemia
Europe’s medicines regulator has begun a new review of Ariad Pharmaceuticals’ leukaemia drug Iclusig, looking in particular at the risk …
GSK launches cancer ‘consortium’
December 6, 2013Research and Development, Sales and Marketing Cancer, GSK, octc, oncology, research
GlaxoSmithKline has formed a consortium of cancer research organisations in North America and Europe in a bid to accelerate the …
FleishmanHillard hires senior head from Edelman
December 6, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FleishmanHillard, tolk
Comms and PR global agency FleishmanHillard has appointed Jerry Tolk to be its senior VP, partner and general manager in …
NICE wants more Lemtrada data
December 6, 2013Sales and Marketing Lemtrada, MS, NICE, Sanofi
NICE has said there are ‘still questions to be answered’ over Sanofi’s submission of its multiple sclerosis drug Lemtrada and …
Court annuls EMA data decision
December 5, 2013Medical Communications, Sales and Marketing AbbVie, EMA, Goldacre, InterMune, alltrials, transparency
The European Court of Justice has annulled interim injunctions against the European Medicines Agency issued earlier this year after AbbVie …
New insulin scores for Sanofi
December 5, 2013Research and Development, Sales and Marketing Lantus, Sanofi, diabetes, u300
Sanofi has been cheered after late-stage results from its investigational insulin U300 showed that the product may have advantages over …
British Safety Council appoints new commercial director
December 5, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BSC, richard evens
Not-for-profit organisation The British Safety Council has appointed Richard Evens as its new commercial director. Evens will be responsible for …
Astellas seeks Xtandi extension
December 5, 2013Sales and Marketing Astellas, Cancer, EU, FDA, US, Xtandi
Astellas Pharma and development partner Medivation are seeking to extend the reach of oncology brand Xtandi by conducting a trial …
Pfizer head to be ABPI president
December 4, 2013Medical Communications, Sales and Marketing ABPI, MSD, PPRS, Pfizer, Whitehead, emms, khanna
The UK managing director of Pfizer Jonathan Emms is to replace Deepak Khanna as the ABPI president from April next …
Pfizer expands in Poland
December 4, 2013Sales and Marketing OTC, Pfizer, Poland, polocard, zf polpharma
Pfizer has bought the rights to one of Poland’s biggest OTC brands in a move which sees the US group …
Forest cuts jobs in restructure
December 4, 2013Research and Development, Sales and Marketing Forest Labs, R&D, US, cuts
Forest Laboratories is restructuring and shedding jobs in a bid to save $500 million in costs by the end of …
Prime minister backs GSK in corruption row
December 4, 2013Medical Communications, Sales and Marketing China, GSK, bribery, david cameron
Prime minister David Cameron has defended London-based pharma giant GlaxoSmithKline over its treatment in China during a visit to the …
Just:: Health hires new director from Edelman
December 4, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Just: Health, Just:: Health
Just:: Health Communications has hired Catherine Barnett to strengthen its senior management team from January next year. Barnett is currently …
Celgene signs $177 million OncoMed deal
December 4, 2013Research and Development, Sales and Marketing Cancer, Celgene, OncoMed, stem cell
Celgene Corporation is paying OncoMed Pharmaceuticals $177.25 million to get access to its pipeline as part of a deal to …
Report: ‘R&D isn’t paying’
December 3, 2013Research and Development, Sales and Marketing Deloitte, R&D, pharma, research and development, reuters
On average, the world’s biggest pharma companies are not getting enough of a return out of their R&D efforts, according …
£10 million competition for gene mapping
December 3, 2013Research and Development, Sales and Marketing DNA, UK, cansar, genes, mapping
The Department of Health has launched a £10 million competition to fund businesses working on new technology which will map …
Witty goes to China
December 3, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing China, GSK, Witty, bribery
GlaxoSmithKline chief executive Sir Andrew Witty has embarked on a potentially delicate diplomatic mission as part of a UK trade …
Aptuit hires chief executive from ICON
December 3, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Aptuit, ICON, goldman
Drug development services firm Aptuit has named Dr Jonathan Goldman as its chief executive, completing the company’s senior management leadership …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
